Previous Close | 1.8100 |
Open | 1.8000 |
Bid | 1.8200 x 29200 |
Ask | 1.8400 x 38500 |
Day's Range | 1.7800 - 1.8700 |
52 Week Range | 1.1600 - 4.3500 |
Volume | |
Avg. Volume | 7,382,073 |
Market Cap | 549.311M |
Beta (5Y Monthly) | 2.25 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.3280 |
Earnings Date | Feb 27, 2023 - Mar 03, 2023 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 6.70 |
Here is how Bionano Genomics, Inc. (BNGO) and Aziyo Biologics, Inc. (AZYO) have performed compared to their sector so far this year.
SAN DIEGO, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Bionano Laboratories today announced the launch of OGM-Dx™ HemeOne™, a laboratory developed test (LDT) based on optical genome mapping (OGM) analysis of blood or bone marrow samples to detect structural variants (SVs) of diagnostic and prognostic utility in individuals with a new or an existing diagnosis of a hematological malignancy. Compared to traditional cytogenetic methods, this OGM-based assay offers a streamlined and improved workflow to assess
Bionano Prep SP-G2 (SP-G2) kit offers higher gDNA quality, improved ease-of-use and increased DNA throughputBionano Prep Direct Label and Stain-G2 (DLS-G2) kit offers increased reagent stability and labeling efficiency resulting in significantly faster sample to results workflowSaphyr Chip® G3.3, instrument control software (ICS) version 5.3 and Bionano Access™ software version 1.7.2 offer enhanced evaporation control and workflow robustness enabling for more high coverage samples to be run per